Related Experiment Video
Updated: Sep 16, 2025

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
Published on: October 24, 2019
Beyond T-cell subsets: stemness and adaptation redefining immunity and immunotherapy.
Dawei Zou1, Xian C Li1,2, Wenhao Chen3,4
1Immunobiology & Transplant Science Center, Department of Surgery, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, USA.
Stem-like CD4+ T cells are crucial reservoirs for effector cell differentiation, driving adaptive immunity in various diseases. Understanding their plasticity offers new therapeutic targets for autoimmunity and cancer.
Area of Science:
- Immunology
- Cell Biology
- T-cell Biology
Background:
- Traditional CD4+ T cell classification into subsets (Th1, Th2, Th17, Tfh) has limitations in explaining persistent immune responses.
- Recent research highlights stemness and adaptation as fundamental to CD4+ T cell function.
Purpose of the Study:
- To explore the role of TCF1+ stem-like CD4+ T cells in immune responses.
- To define the concept of clonal adaptation in T cell differentiation.
- To assess the therapeutic potential of targeting stem-like CD4+ T cells.
Main Methods:
- Analysis of CD4+ T cell phenotypes and functional states post-activation.
- Investigation of TCF1+ stem-like CD4+ T cell populations.
- Studying T cell dynamics in autoimmunity, transplant rejection, chronic infections, and cancer models.
Main Results:
- TCF1+ stem-like CD4+ T cells emerge early post-activation, serving as a reservoir for effector differentiation.
- These cells dynamically integrate environmental cues for clonal adaptation, influencing effector function.
- Stem-like CD4+ T cells sustain chronic immune responses but can become dysfunctional in tolerogenic or tumor environments.
Conclusions:
- Stem-like CD4+ T cells are key regulators of adaptive immunity, balancing self-renewal and effector differentiation.
- Targeting these cells could mitigate autoimmune diseases and transplant rejection.
- Enhancing their effector function may improve anti-tumor immunity.
More Related Videos
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Cell-mediated Immune Responses
Cells of the Adaptive Immune Response
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Tumor Immunotherapy

